MedTrace Logo

Multi-omics Analysis of Chronic Kidney Disease

NCT05543291 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-09-16

No results posted yet for this study

Summary

Chronic kidney disease (CKD) is a progressive disease with hidden epidemics and one of the most significant contributing factors to end-stage renal disease (ESRD), cardiovascular comorbidities, cachexia and anemia, which accounts for a nearly 1.2 million populations died per year.

Conditions

  • Potential Mechanisms Underlying the Microbiota-Gut-Kidney Axis in CKD

Interventions

BEHAVIORAL

renal function

levels of eGFR

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05543291 on ClinicalTrials.gov